Ivantis

Replay
Cancel

Your 25-second video preview has ended.

to continue watching, please Log In or Register:


Log in / Register

HORIZON: Largest Ever MIGS Pivotal Trial

Ike Ahmed, MD, reviews the HORIZON trial at an Ivantis symposium at the 2019 ASCRS annual meeting. HORIZON is the largest microinvasive glaucoma surgery pivotal trial to date, including 556 patients across multiple countries. The study includes patients with mild to moderate glaucoma, and it will follow patients out to 5 years.